ScreenerHero

CURX Curanex Pharmaceuticals Inc

NAS · US · Healthcare · Biotechnology · curanexpharma.com
4.770USD-4.41%Mkt Cap: 7.48M $P/E: —

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap7.48M USD
Enterprise Value5.16M USD
Revenue (TTM)—
Gross Profit-7.84M USD
Net Income (TTM)-4.23M USD
Revenue/Share—
Last Price4.770 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.48
EPS (TTM)-8.33
EPS (Forward)—
52W Range
3.5761% of range90.00
52W High90.00 USD
52W Low3.576 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-37.66%
ROA-36.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.48M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-103.13%
Net Debt-2.66M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.03
Current Ratio45.95
Quick Ratio28.17
Book Value/Sh3.38 USD
Cash/Share1.87 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateAug 20, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.57M
Float505.63K
Insiders61.35%
Institutions1.07%
Short Interest
Short Ratio0.1d
Short % Float0.47%
Short % Out.0.18%
Shares Short2.82K
Short (prev mo.)1.22K
Technical
SMA 504.470 (+6.7%)
SMA 2006.410 (-25.6%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)25.84K
Avg Vol (10d)22.39K
Technical Indicators
RSI (14)48.7
MACD-0.2797
MACD Signal-0.4157
MACD Hist.+0.1360
BB Upper5.196 USD
BB Middle4.644 USD
BB Lower4.093 USD
BB Width23.77%
ATR (14)1.385 USD
Vol Ratio (20d)5.00x